Monograph Details
|
|
Central Nervous System
> Anxiety/OCD
|
|
VISTARIL |
| Manufacturer |
|
Pfizer Labs |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Antihistamine. |
| Generic Name |
|
Hydroxyzine pamoate 25mg, 50mg; caps. |
| Also |
|
• VISTARIL SUSPENSION
|
| Indications |
|
Short-term management of anxiety. |
| Children |
|
<6 years: 50mg daily. ≥6 years: 50–100mg daily. Both in divided doses. |
| Adults |
|
50–100mg 4 times daily. |
| Contraindications |
|
Early pregnancy. Nursing mothers. |
| Precautions |
|
Therapy for >4 months. Elderly. |
| Interactions |
|
Potentiates CNS depression with alcohol, other CNS depressants (eg, meperidine, barbiturates). |
| Adverse Reactions |
|
Drowsiness, dry mouth, tremor, convulsions. |
| How Supplied |
Caps—100
Susp—4 oz, pt |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
